The intersection of real estate and life sciences – PropSci – is a continuously evolving sector that impacts industries and transforms the way we do business globally. Companies within the life sciences industry vertical have a profound impact on innovative real estate ideas and opportunities, and the overlap between these two sectors will continue to shape the future of this space.
As a first-of-its-kind group among leading global law firms, Goodwin’s PropSci practice is built to meet biotechnology, pharmaceutical and medical device companies’ challenging real estate demands. The rapid advancements in the life sciences industry requires real estate that is scalable and responsive to deliver products and projects on time and on budget. We know the intricacies of R&D and manufacturing space, as well as the challenges in developing land and buildings for life sciences companies.
Goodwin’s PropSci practice is an extensive, global network of nearly 300 life sciences and real estate lawyers facing the market. Whether advising companies on pre-Series A financing through exits via IPOs and acquisitions, construction and financing of life sciences facilities, or leasing transactions, our PropSci practice works seamlessly to advise companies and investors across all stages and multiple business needs.